http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101107800-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-54
filingDate 2007-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101107800-B1
titleOfInvention Pyrazoline Compounds as Mineral Corticoid Receptor Antagonists
abstract The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof. The invention also relates to corresponding pharmaceutical compositions, methods of treatment and intermediates:n n n Formula In n n n n n n n Wheren n n R 1 , R 2 , R 3A , R 3B , R 4 , R 5 , R 6 , R 7 , R 8 and X are as defined in the detailed description of the invention.
priorityDate 2006-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9809969-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005066161-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59429387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465969428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468316486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410674784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46915194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468316880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411470339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468316879
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59429381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420634407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408968310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164120844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24984074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466315799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465938628
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164100053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148191268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424253533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410097933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410023851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21069828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135870988
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413687416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421033117
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58079862
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59429361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468317060

Total number of triples: 60.